Submit Deal

MERCK GLOBAL HEALTH INNOVATION FUND

Summary

Merck Global Health Innovation Fund (GHI) is evolving corporate healthcare venture capital by utilizing their healthcare ecosystem strategy.

Deals Overview

Total Deals12

Valued Deals11

Total Value£ 6.66 B

Avg. Deal Size£ 605 M

Market Context

Parent Company

MERCK & CO

56 transactions

Senior Management

William Taranto
Chairman
Joel Krikston
Prem Tumkosit
Managing Director

Sort

preventice solutions inc

HQ - United States

Health Care Services

2 Mar 2021

Investment Date

78%

Stake

£ 896 M

Deal Value

m2gen

HQ - United States

Online and Social Platforms

17 Mar 2021

Investment Date

n/a

Deal Value

pathai inc

HQ - United States

Medical Equipment

18 May 2021

Investment Date

£ 116 M

Deal Value

ciox health

HQ - United States

IT Services: Other

28 Jul 2021

Investment Date

100%

Stake

£ 4.95 B

Deal Value

strata oncology

HQ - United States

Biotechnology

28 Jul 2021

Investment Date

£ 64 M

Deal Value

saama technologies inc

HQ - United States

Risk and Compliance

20 Oct 2021

Investment Date

£ 312 M

Deal Value

transcarent

HQ - United States

Health Care Services

11 Feb 2022

Investment Date

12%

Stake

£ 147 M

Deal Value

koneksa health

HQ - United States

Medical Equipment

Biotechnology

7 Feb 2022

Investment Date

£ 37 M

Deal Value

aerosafe global

HQ - United States

Biotechnology

31 Aug 2023

Investment Date

£ 33 M

Deal Value

unnatural products

HQ - United States

Biotechnology

19 Dec 2023

Investment Date

£ 25 M

Deal Value

atropos health

HQ - United States

Medical Services

23 May 2024

Investment Date

£ 25 M

Deal Value

qure.ai

HQ - India

Medical Services

25 Sep 2024

Investment Date

£ 48 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy